Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,717 | -143,750 | -104,586 | -60,452 | -17,349 |
| Depreciation Amortization | 257 | 425 | 172 | -319 | -392 |
| Accounts payable and accrued liabilities | 641 | -1,799 | -922 | -2,231 | -1,910 |
| Other Working Capital | -8,672 | -15,465 | -16,144 | -22,799 | -28,550 |
| Other Operating Activity | 5,796 | 32,077 | 25,171 | 17,805 | 9,694 |
| Operating Cash Flow | $-41,695 | $-128,512 | $-96,309 | $-67,996 | $-38,507 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 27,031 | 117,849 | 88,937 | 39,999 | 5,927 |
| PPE Investments | -44 | -1,041 | -1,248 | -1,419 | -1,144 |
| Investing Cash Flow | $26,987 | $116,808 | $87,689 | $38,580 | $4,783 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 100 | 887 | 695 | 687 | 350 |
| Financing Cash Flow | $100 | $887 | $695 | $687 | $350 |
| Beginning Cash Position | 94,344 | 105,161 | 105,161 | 105,161 | 105,161 |
| End Cash Position | 79,736 | 94,344 | 97,236 | 76,432 | 71,787 |
| Net Cash Flow | $-14,608 | $-10,817 | $-7,925 | $-28,729 | $-33,374 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,695 | -128,512 | -96,309 | -67,996 | -38,507 |
| Capital Expenditure | -44 | -1,041 | -1,248 | -1,419 | -1,144 |
| Free Cash Flow | -41,739 | -129,553 | -97,557 | -69,415 | -39,651 |